We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
DCXR
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • DCXR
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

DCXR is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 210.91
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 886.6
Number of samples 362
Samples
Sample Description pTPM
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 7234.5
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 5143.6
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 4979.4
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 4274.9
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 3920.3
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 3913.5
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 3722.3
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 3565.8
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 3421.2
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 3227.4
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 3196.8
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 3034.3
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 3002.3
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 3001.6
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 2979.2
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 2895.9
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 2842.5
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 2819.2
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 2778.3
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 2775.5
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 2762.6
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 2671.7
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 2655.5
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 2580.8
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 2529.6
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 2481.5
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 2401.1
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 2393.0
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 2365.5
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 2267.1
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 2242.6
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 2206.7
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 2177.5
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 2170.9
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 2131.9
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 2127.9
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 2104.4
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 2059.3
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 2021.7
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 2004.7
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 1978.0
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 1956.0
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 1942.8
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 1928.7
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 1898.6
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 1861.9
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 1861.6
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 1852.9
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 1844.2
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 1825.7
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 1783.1
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 1759.4
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 1747.6
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 1734.8
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 1725.7
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 1709.7
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 1675.7
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 1664.8
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 1658.1
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 1651.3
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 1609.8
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 1595.8
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 1584.1
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 1575.0
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 1570.8
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 1564.6
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 1555.7
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 1538.6
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 1504.4
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 1500.5
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 1495.7
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 1489.5
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 1482.4
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 1469.4
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 1447.8
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 1438.7
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 1421.9
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 1415.7
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 1388.4
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 1373.1
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 1371.4
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 1361.8
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 1345.9
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 1272.6
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 1258.4
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 1256.3
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 1248.7
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 1237.7
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 1236.1
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 1217.8
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 1216.1
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 1196.1
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 1151.6
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 1150.0
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 1146.0
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 1131.9
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 1126.2
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 1125.2
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 1092.7
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 1067.9
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 1046.8
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 1031.1
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 1024.2
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 1008.8
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 999.2
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 998.1
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 989.1
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 984.3
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 977.2
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 971.2
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 965.6
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 965.4
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 954.2
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 949.6
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 948.0
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 946.3
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 941.6
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 912.4
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 902.6
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 898.8
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 884.5
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 884.4
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 880.3
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 880.0
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 877.6
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 874.4
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 872.2
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 857.3
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 853.8
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 849.1
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 845.0
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 837.5
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 834.2
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 834.2
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 820.6
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 820.0
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 816.7
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 815.1
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 815.1
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 812.0
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 808.3
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 799.3
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 795.2
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 787.8
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 785.9
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 774.9
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 766.7
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 761.5
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 741.8
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 741.6
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 723.8
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 713.5
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 703.6
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 695.2
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 694.3
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 688.4
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 675.4
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 662.3
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 659.3
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 658.9
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 657.8
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 650.6
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 648.0
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 637.8
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 634.0
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 630.6
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 629.3
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 626.5
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 624.5
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 615.9
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 613.3
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 604.2
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 604.1
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 601.9
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 591.3
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 584.4
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 575.1
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 574.2
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 572.6
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 570.9
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 567.0
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 554.1
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 552.1
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 550.6
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 543.9
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 535.7
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 529.2
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 525.1
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 525.1
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 520.2
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 517.8
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 506.0
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 504.5
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 502.8
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 501.9
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 481.4
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 473.6
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 465.3
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 464.8
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 457.6
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 455.0
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 446.3
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 443.1
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 441.7
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 439.8
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 439.2
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 438.8
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 434.9
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 428.7
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 427.7
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 421.8
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 421.8
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 420.3
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 418.8
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 416.8
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 416.1
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 409.9
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 408.5
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 406.2
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 400.4
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 397.6
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 389.2
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 386.7
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 386.1
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 383.8
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 381.3
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 378.8
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 373.9
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 373.7
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 373.4
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 369.7
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 369.5
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 366.3
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 366.2
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 359.1
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 357.9
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 355.3
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 347.0
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 344.1
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 340.8
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 336.7
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 333.5
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 332.4
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 326.6
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 324.3
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 322.6
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 320.9
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 320.4
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 319.8
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 317.7
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 312.9
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 312.5
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 308.1
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 304.3
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 303.2
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 301.4
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 298.5
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 292.1
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 285.7
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 278.7
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 277.4
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 277.2
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 273.1
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 268.1
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 262.1
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 261.9
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 259.6
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 259.0
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 254.5
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 250.9
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 248.8
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 246.2
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 246.1
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 240.7
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 236.5
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 235.9
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 234.2
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 231.0
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 230.3
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 223.5
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 222.0
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 221.6
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 220.1
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 218.0
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 215.8
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 215.7
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 211.3
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 210.9
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 209.7
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 207.6
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 199.3
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 199.3
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 192.8
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 190.3
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 189.8
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 189.3
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 188.6
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 187.8
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 183.5
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 181.6
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 179.3
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 178.7
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 176.2
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 175.3
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 173.4
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 172.9
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 172.6
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 172.1
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 171.8
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 170.1
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 168.9
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 166.5
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 165.4
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 158.2
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 156.6
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 151.5
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 146.5
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 146.5
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 145.1
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 141.8
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 137.7
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 135.9
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 133.5
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 123.7
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 122.4
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 121.7
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 121.4
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 118.2
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 115.4
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 110.8
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 107.7
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 104.4
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 101.7
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 99.4
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 93.9
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 93.6
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 92.9
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 91.2
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 90.8
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 88.1
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 82.9
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 79.5
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 77.4
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 75.4
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 74.0
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 72.2
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 70.4
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 69.8
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 69.0
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 67.2
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 66.9
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 63.3
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 60.2
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 54.7
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 53.2
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 51.6
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 48.6
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 39.3
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 38.0
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 34.2
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 23.8
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 22.7
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

DCXR is potential prognostic, high expression is favorable in Liver Hepatocellular Carcinoma (validation)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 901.6
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 1097.0
Number of samples 231
Samples
Sample Description pTPM
DO50822 66 years, male, NA, stage:2, alive, 510 days 8118.8
DO50816 63 years, male, NA, stage:2, alive, 390 days 7980.7
DO50814 83 years, male, NA, stage:3, alive, 420 days 6224.0
DO50839 47 years, female, NA, stage:3, alive, 330 days 5801.1
DO45175 74 years, male, NA, stage:2, alive, 1140 days 5402.7
DO48759 73 years, male, NA, stage:3, alive, 720 days 4684.3
DO23548 78 years, female, NA, stage:1, alive, 840 days 4545.4
DO50802 49 years, male, NA, stage:2, alive, 930 days 4426.7
DO45255 81 years, male, NA, stage:3, alive, 720 days 4158.6
DO45125 58 years, male, NA, stage:3, alive, 1680 days 4135.5
DO23539 77 years, male, NA, stage:1, alive, 1110 days 3912.1
DO45133 64 years, male, NA, stage:3, dead, 660 days 3681.7
DO23536 56 years, male, NA, stage:2, alive, 930 days 3587.6
DO50832 73 years, male, NA, stage:3, alive, 90 days 3543.2
DO45129 61 years, male, NA, stage:3, alive, 1470 days 3515.9
DO50817 75 years, male, NA, stage:2, alive, 390 days 3443.7
DO23533 61 years, male, NA, stage:2, alive, 900 days 3422.5
DO23534 60 years, male, NA, stage:2, alive, 840 days 3151.8
DO48719 80 years, male, NA, stage:2, alive, 690 days 3141.7
DO45163 76 years, male, NA, stage:2, alive, 960 days 2960.8
DO45281 83 years, male, NA, stage:4, alive, 750 days 2838.4
DO50818 65 years, male, NA, stage:2, alive, 510 days 2745.6
DO48677 58 years, male, NA, stage:3, alive, 1140 days 2736.5
DO23549 74 years, male, NA, stage:3, alive, 990 days 2720.7
DO50825 70 years, male, NA, stage:2, alive, 390 days 2717.7
DO23525 71 years, male, NA, stage:4, alive, 1050 days 2661.2
DO48674 80 years, male, NA, stage:2, alive, 1260 days 2527.6
DO48695 77 years, male, NA, stage:2, alive, 720 days 2527.4
DO23532 71 years, female, NA, stage:1, alive, 960 days 2525.0
DO50804 81 years, male, NA, stage:2, alive, 720 days 2492.9
DO50813 56 years, male, NA, stage:2, alive, 420 days 2449.1
DO48693 71 years, male, NA, stage:2, alive, 900 days 2207.7
DO227643 79 years, male, NA, stage:2, alive, 1260 days 2162.9
DO50787 63 years, male, NA, stage:3, alive, 480 days 2119.9
DO45097 69 years, male, NA, stage:3, alive, 1620 days 2057.3
DO45101 63 years, male, NA, stage:2, alive, 1680 days 2038.7
DO50840 49 years, male, NA, stage:2, alive, 330 days 2017.7
DO23542 66 years, male, NA, stage:3, alive, 960 days 1972.7
DO48672 81 years, male, NA, stage:2, alive, 450 days 1898.1
DO45195 62 years, male, NA, stage:1, alive, 390 days 1864.3
DO45117 73 years, female, NA, stage:2, dead, 1110 days 1848.6
DO45215 65 years, male, NA, stage:2, alive, 1170 days 1828.4
DO45261 74 years, male, NA, stage:3, alive, 990 days 1813.7
DO23529 72 years, male, NA, stage:4, alive, 930 days 1786.4
DO45177 81 years, female, NA, stage:3, alive, 1260 days 1744.2
DO23543 63 years, male, NA, stage:2, alive, 1020 days 1699.9
DO50789 73 years, female, NA, stage:2, alive, 570 days 1681.5
DO48721 58 years, female, NA, stage:1, alive, 900 days 1649.1
DO23546 63 years, male, NA, stage:2, alive, 1050 days 1618.7
DO23544 67 years, male, NA, stage:2, alive, 960 days 1604.7
DO50783 62 years, male, NA, stage:3, alive, 480 days 1596.9
DO45107 63 years, female, NA, stage:2, alive, 1710 days 1503.3
DO48679 72 years, male, NA, stage:2, alive, 1200 days 1487.6
DO48716 71 years, male, NA, stage:2, alive, 720 days 1428.2
DO23514 64 years, male, NA, stage:2, alive, 1290 days 1424.4
DO45167 67 years, male, NA, stage:2, dead, 1440 days 1419.2
DO50807 67 years, male, NA, stage:1, alive, 540 days 1376.8
DO23511 83 years, female, NA, stage:3, dead, 180 days 1351.6
DO48701 78 years, male, NA, stage:2, alive, 780 days 1325.0
DO45105 61 years, male, NA, stage:1, alive, 1680 days 1304.9
DO45111 74 years, male, NA, stage:2, alive, 1590 days 1251.7
DO23540 73 years, male, NA, stage:1, alive, 750 days 1240.3
DO23512 60 years, male, NA, stage:1, alive, 1260 days 1220.1
DO48742 76 years, male, NA, stage:2, alive, 600 days 1195.8
DO50859 77 years, male, NA, stage:2, alive, 180 days 1184.5
DO48741 64 years, male, NA, stage:3, alive, 240 days 1184.4
DO23528 45 years, female, NA, stage:2, alive, 1020 days 1168.4
DO45095 66 years, male, NA, stage:2, alive, 1620 days 1143.1
DO23517 62 years, male, NA, stage:2, alive, 1200 days 1132.3
DO23516 69 years, male, NA, stage:3, dead, 20 days 1131.6
DO45229 74 years, male, NA, stage:1, alive, 990 days 1119.8
DO50811 62 years, male, NA, stage:1, alive, 450 days 1115.6
DO48681 57 years, male, NA, stage:2, alive, 900 days 1101.6
DO45227 57 years, female, NA, stage:2, alive, 1020 days 1095.8
DO45181 84 years, female, NA, stage:2, alive, 1200 days 1077.2
DO23509 60 years, male, NA, stage:3, dead, 780 days 1074.0
DO45253 50 years, male, NA, stage:2, alive, 870 days 1072.6
DO23513 76 years, male, NA, stage:3, alive, 1200 days 1071.5
DO45171 56 years, male, NA, stage:3, alive, 600 days 1032.7
DO45099 46 years, male, NA, stage:3, alive, 1590 days 1020.7
DO50776 75 years, male, NA, stage:1, alive, 690 days 1014.5
DO45113 58 years, male, NA, stage:3, alive, 1560 days 1003.5
DO23541 65 years, male, NA, stage:2, alive, 930 days 990.8
DO45241 49 years, male, NA, stage:1, alive, 1080 days 976.7
DO23527 72 years, male, NA, stage:1, alive, 1050 days 926.6
DO48757 68 years, female, NA, stage:3, alive, 480 days 913.2
DO48706 72 years, male, NA, stage:2, alive, 870 days 908.8
DO45153 77 years, female, NA, stage:2, alive, 1380 days 908.6
DO45093 71 years, male, NA, stage:2, dead, 720 days 894.6
DO45109 63 years, male, NA, stage:2, alive, 1590 days 889.4
DO48727 81 years, female, NA, stage:2, dead, 390 days 885.0
DO45149 70 years, female, NA, stage:2, alive, 1260 days 881.7
DO50791 79 years, female, NA, stage:1, dead, 480 days 865.8
DO50809 56 years, male, NA, stage:3, dead, 720 days 860.9
DO45123 78 years, female, NA, stage:2, dead, 570 days 846.8
DO48704 68 years, female, NA, stage:3, alive, 750 days 838.0
DO23550 69 years, male, NA, stage:1, alive, 990 days 805.6
DO50798 77 years, male, NA, stage:3, dead, 30 days 805.2
DO50808 68 years, male, NA, stage:2, alive, 570 days 799.0
DO45179 78 years, female, NA, stage:2, alive, 600 days 798.0
DO45199 86 years, female, NA, stage:2, alive, 1350 days 797.5
DO23531 78 years, female, NA, stage:3, alive, 900 days 775.5
DO45267 73 years, male, NA, stage:3, dead, 570 days 771.0
DO45235 68 years, female, NA, stage:1, alive, 900 days 770.4
DO48746 76 years, male, NA, stage:3, alive, 570 days 749.9
DO50857 72 years, male, NA, stage:2, alive, 210 days 735.7
DO45207 68 years, male, NA, stage:1, alive, 1050 days 724.3
DO48737 52 years, male, NA, stage:1, alive, 720 days 708.1
DO50793 76 years, male, NA, stage:4, alive, 540 days 695.4
DO23526 66 years, male, NA, stage:3, alive, 1050 days 688.4
DO45094 76 years, male, NA, stage:3, alive, 1650 days 681.1
DO23538 67 years, male, NA, stage:2, alive, 450 days 673.1
DO48715 58 years, female, NA, stage:2, dead, 690 days 662.8
DO50819 72 years, female, NA, stage:2, alive, 510 days 654.9
DO45273 62 years, male, NA, stage:2, alive, 480 days 637.5
DO48760 70 years, female, NA, stage:2, alive, 690 days 630.9
DO45143 69 years, male, NA, stage:3, alive, 1290 days 617.6
DO48751 68 years, male, NA, stage:2, dead, 480 days 608.8
DO48723 73 years, male, NA, stage:1, alive, 600 days 602.9
DO45119 74 years, male, NA, stage:3, dead, 510 days 590.7
DO45096 69 years, male, NA, stage:2, dead, 1290 days 580.8
DO23547 74 years, male, NA, stage:1, alive, 1020 days 552.9
DO45201 49 years, male, NA, stage:1, alive, 900 days 535.9
DO45193 68 years, female, NA, stage:4, dead, 120 days 534.6
DO45233 83 years, male, NA, stage:3, alive, 900 days 528.6
DO48733 72 years, male, NA, stage:2, alive, 600 days 511.8
DO48700 78 years, female, NA, stage:2, alive, 810 days 508.1
DO48732 73 years, male, NA, stage:3, alive, 630 days 506.0
DO50774 68 years, female, NA, stage:2, alive, 720 days 505.9
DO50806 70 years, male, NA, stage:4, alive, 540 days 499.8
DO23551 73 years, male, NA, stage:3, dead, 150 days 498.4
DO23508 79 years, female, NA, stage:2, alive, 390 days 496.3
DO50800 74 years, male, NA, stage:2, alive, 510 days 495.6
DO45155 69 years, male, NA, stage:2, alive, 2160 days 493.5
DO45169 74 years, male, NA, stage:3, alive, 1350 days 483.0
DO45225 69 years, male, NA, stage:1, alive, 1050 days 481.4
DO227801 77 years, female, NA, stage:1, alive, 660 days 480.8
DO50805 72 years, male, NA, stage:2, alive, 690 days 463.5
DO45131 53 years, male, NA, stage:4, dead, 360 days 456.2
DO50850 74 years, male, NA, stage:3, alive, 720 days 455.9
DO23537 79 years, male, NA, stage:2, dead, 900 days 455.3
DO45243 74 years, female, NA, stage:3, alive, 930 days 455.2
DO23545 67 years, male, NA, stage:2, dead, 570 days 447.3
DO45197 51 years, male, NA, stage:2, alive, 1170 days 436.6
DO50844 75 years, male, NA, stage:4, alive, 300 days 432.1
DO48697 64 years, female, NA, stage:2, dead, 810 days 421.8
DO23535 67 years, male, NA, stage:1, alive, 960 days 417.0
DO50799 66 years, female, NA, stage:2, alive, 540 days 416.3
DO45223 67 years, male, NA, stage:4, alive, 1020 days 408.5
DO50803 62 years, female, NA, stage:1, alive, 540 days 389.3
DO45103 47 years, male, NA, stage:3, alive, 450 days 386.6
DO45141 73 years, male, NA, stage:2, alive, 1320 days 378.7
DO45217 69 years, female, NA, stage:3, dead, 270 days 375.9
DO48712 50 years, male, NA, stage:2, alive, 810 days 368.3
DO45161 74 years, male, NA, stage:2, dead, 540 days 362.6
DO45209 70 years, male, NA, stage:4, alive, 1350 days 356.7
DO45173 63 years, male, NA, stage:3, alive, 1170 days 352.5
DO48743 69 years, female, NA, stage:2, alive, 570 days 338.5
DO48761 55 years, male, NA, stage:2, alive, 870 days 336.4
DO45092 62 years, male, NA, stage:4, dead, 1200 days 330.2
DO45237 58 years, male, NA, stage:2, alive, 900 days 325.9
DO45115 81 years, male, NA, stage:2, alive, 840 days 325.1
DO23518 67 years, male, NA, stage:2, alive, 1320 days 314.2
DO45221 75 years, female, NA, stage:4, dead, 390 days 300.9
DO48736 76 years, female, NA, stage:1, alive, 600 days 298.9
DO45127 73 years, male, NA, stage:3, dead, 420 days 298.8
DO45231 84 years, male, NA, stage:2, alive, 930 days 286.0
DO45219 78 years, male, NA, stage:2, alive, 1080 days 285.7
DO45185 89 years, male, NA, stage:2, alive, 600 days 277.9
DO50785 37 years, male, NA, stage:4, dead, 90 days 273.2
DO45159 65 years, male, NA, stage:3, alive, 1470 days 271.8
DO45139 63 years, male, NA, stage:3, alive, 1320 days 267.4
DO50845 72 years, male, NA, stage:3, alive, 210 days 256.3
DO45165 75 years, male, NA, stage:2, alive, 690 days 256.0
DO45257 46 years, male, NA, stage:3, alive, 810 days 250.7
DO50820 77 years, female, NA, stage:3, alive, 510 days 246.5
DO23552 80 years, female, NA, stage:1, alive, 810 days 245.0
DO45091 56 years, male, NA, stage:2, dead, 1320 days 244.1
DO48725 66 years, male, NA, stage:1, alive, 780 days 243.3
DO23510 80 years, female, NA, stage:2, alive, 870 days 240.4
DO45137 38 years, male, NA, stage:1, alive, 1320 days 232.9
DO48717 54 years, male, NA, stage:4, dead, 180 days 226.0
DO45211 76 years, male, NA, stage:3, alive, 240 days 222.6
DO45251 57 years, female, NA, stage:2, alive, 900 days 217.6
DO50829 78 years, male, NA, stage:3, alive, 570 days 210.2
DO50855 47 years, male, NA, stage:2, alive, 570 days 209.3
DO45299 70 years, female, NA, stage:1, alive, 1440 days 208.3
DO48682 72 years, female, NA, stage:3, dead, 120 days 206.5
DO45121 61 years, male, NA, stage:3, alive, 1530 days 201.3
DO48747 62 years, male, NA, stage:3, alive, 540 days 193.6
DO23530 53 years, male, NA, stage:4, dead, 180 days 191.5
DO45301 56 years, male, NA, stage:2, dead, 1440 days 185.8
DO45249 57 years, male, NA, stage:1, alive, 630 days 182.7
DO45269 59 years, male, NA, stage:3, alive, 750 days 181.9
DO45157 62 years, male, NA, stage:2, alive, 1980 days 177.8
DO23519 65 years, male, NA, stage:3, alive, 630 days 168.7
DO45247 31 years, female, NA, stage:2, alive, 210 days 168.5
DO45135 77 years, male, NA, stage:1, alive, 1410 days 167.2
DO50815 62 years, male, NA, stage:3, alive, 150 days 166.1
DO45213 58 years, male, NA, stage:1, alive, 1200 days 163.3
DO45183 72 years, female, NA, stage:2, dead, 570 days 153.3
DO23521 63 years, male, NA, stage:3, alive, 1110 days 151.0
DO45145 78 years, male, NA, stage:3, dead, 60 days 150.6
DO45263 67 years, male, NA, stage:3, dead, 270 days 149.7
DO23515 71 years, male, NA, stage:2, alive, 1230 days 147.3
DO45187 32 years, female, NA, stage:1, alive, 1260 days 142.3
DO48730 73 years, female, NA, stage:2, alive, 630 days 141.2
DO23523 52 years, male, NA, stage:3, alive, 1080 days 136.8
DO45239 42 years, male, NA, stage:2, alive, 870 days 131.2
DO45283 60 years, male, NA, stage:3, alive, 510 days 127.8
DO45287 74 years, male, NA, stage:1, alive, 390 days 123.9
DO45275 65 years, male, NA, stage:3, dead, 10 days 120.6
DO45265 73 years, male, NA, stage:3, alive, 1020 days 115.7
DO50778 60 years, male, NA, stage:4, alive, 630 days 115.0
DO45191 61 years, female, NA, stage:2, alive, 1200 days 112.1
DO45203 71 years, female, NA, stage:2, alive, 1170 days 104.2
DO48720 62 years, female, NA, stage:2, alive, 570 days 93.1
DO45297 61 years, female, NA, stage:4, dead, 1260 days 92.5
DO45277 64 years, male, NA, stage:3, alive, 600 days 90.0
DO23524 71 years, female, NA, stage:2, alive, 1050 days 84.4
DO45205 67 years, female, NA, stage:2, dead, 90 days 82.4
DO45245 75 years, female, NA, stage:2, dead, 240 days 81.7
DO45305 66 years, male, NA, stage:4, alive, 300 days 80.3
DO45289 78 years, female, NA, stage:3, alive, 360 days 77.8
DO48728 74 years, female, NA, stage:2, alive, 150 days 77.4
DO45307 54 years, female, NA, stage:4, dead, 240 days 75.8
DO45285 59 years, male, NA, stage:3, alive, 480 days 72.1
DO45259 65 years, male, NA, stage:3, alive, 330 days 67.6
DO45279 67 years, male, NA, stage:3, alive, 1290 days 64.3
DO45189 85 years, female, NA, stage:2, alive, 1200 days 54.9
DO45303 62 years, female, NA, stage:3, alive, 990 days 48.9
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
741 Tumor 1.3
981 Tumor 1.1
222 Normal 1.1
128 Normal 1.1
172 Normal 1.0
196 Normal 1.0
132 Normal 1.0
484 Normal 1.0
648 Normal 0.9
342 Normal 0.9
162 Normal 0.9
452 Normal 0.9
627 Tumor 0.9
366 Normal 0.9
436 Normal 0.8
278 Normal 0.8
464 Normal 0.8
867 Tumor 0.8
466 Normal 0.8
824 Normal 0.8
618 Normal 0.8
938 Normal 0.8
258 Normal 0.8
742 Normal 0.8
414 Normal 0.8
568 Normal 0.8
394 Normal 0.7
358 Normal 0.7
298 Normal 0.7
232 Normal 0.7
314 Normal 0.7
272 Normal 0.7
534 Normal 0.7
432 Normal 0.7
636 Normal 0.7
746 Normal 0.7
915 Tumor 0.7
148 Normal 0.7
878 Normal 0.7
388 Normal 0.7
376 Normal 0.7
448 Normal 0.7
465 Tumor 0.7
114 Normal 0.7
396 Normal 0.7
698 Normal 0.7
136 Normal 0.6
138 Normal 0.6
186 Normal 0.6
462 Normal 0.6
564 Normal 0.6
356 Normal 0.6
786 Normal 0.6
112 Tumor 0.6
858 Normal 0.6
332 Normal 0.6
446 Normal 0.6
744 Normal 0.6
572 Normal 0.6
428 Normal 0.6
482 Normal 0.6
111 Normal 0.6
862 Normal 0.6
426 Normal 0.6
714 Normal 0.6
911 Tumor 0.6
616 Normal 0.6
628 Normal 0.6
1022 Normal 0.6
664 Normal 0.6
468 Normal 0.6
914 Normal 0.6
738 Normal 0.5
882 Normal 0.5
422 Normal 0.5
861 Tumor 0.5
424 Normal 0.5
488 Normal 0.5
864 Normal 0.5
228 Normal 0.5
666 Normal 0.5
412 Normal 0.5
546 Normal 0.5
642 Normal 0.5
456 Normal 0.5
1026 Normal 0.5
392 Normal 0.5
756 Normal 0.5
662 Normal 0.5
866 Normal 0.5
362 Normal 0.5
477 Tumor 0.5
912 Normal 0.4
354 Normal 0.4
696 Normal 0.4
494 Normal 0.4
423 Tumor 0.4
472 Normal 0.4
818 Normal 0.4
944 Normal 0.4
816 Normal 0.4
1032 Normal 0.4
431 Tumor 0.4
1016 Normal 0.4
474 Normal 0.4
922 Normal 0.4
518 Normal 0.4
312 Normal 0.4
142 Normal 0.4
728 Normal 0.4
352 Normal 0.4
1046 Normal 0.4
574 Normal 0.4
982 Normal 0.4
722 Normal 0.4
214 Normal 0.4
964 Normal 0.4
344 Normal 0.3
364 Normal 0.3
286 Normal 0.3
723 Tumor 0.3
924 Normal 0.3
328 Normal 0.3
124 Normal 0.3
976 Normal 0.3
1041 Tumor 0.3
926 Normal 0.3
526 Normal 0.3
146 Normal 0.3
884 Normal 0.3
874 Normal 0.3
1014 Normal 0.3
516 Normal 0.3
368 Normal 0.2
686 Normal 0.2
416 Normal 0.2
1028 Normal 0.2
126 Normal 0.2
262 Normal 0.2
558 Normal 0.2
261 Tumor 0.2
361 Tumor 0.2
386 Normal 0.2
433 Tumor 0.2
918 Normal 0.2
435 Tumor 0.2
218 Normal 0.2
966 Normal 0.2
1042 Normal 0.2
284 Normal 0.2
954 Normal 0.1
716 Normal 0.1
958 Normal 0.1
353 Tumor 0.1
554 Normal 0.1
978 Normal 0.1
365 Tumor 0.1
952 Normal 0.1
514 Normal 0.1
956 Normal 0.1
778 Normal 0.1
528 Normal 0.1
984 Normal 0.1
384 Normal 0.0
1044 Normal 0.0
212 Normal 0.0
968 Normal 0.0
672 Normal 0.0
868 Normal 0.0
268 Normal 0.0
444 Normal 0.0
188 Normal -0.1
481 Tumor -0.1
451 Tumor -0.1
852 Normal -0.1
434 Normal -0.1
538 Normal -0.1
755 Tumor -0.1
141 Tumor -0.2
615 Tumor -0.2
695 Tumor -0.2
224 Normal -0.2
1027 Tumor -0.2
123 Tumor -0.2
478 Normal -0.2
137 Tumor -0.2
916 Normal -0.3
487 Tumor -0.3
127 Tumor -0.3
192 Normal -0.3
955 Tumor -0.3
873 Tumor -0.3
171 Tumor -0.3
492 Normal -0.3
515 Tumor -0.3
785 Tumor -0.3
498 Normal -0.4
977 Tumor -0.4
217 Tumor -0.4
513 Tumor -0.4
145 Tumor -0.5
1045 Tumor -0.5
231 Tumor -0.5
415 Tumor -0.5
524 Normal -0.5
745 Tumor -0.5
1015 Tumor -0.5
665 Tumor -0.5
327 Tumor -0.6
267 Tumor -0.6
195 Tumor -0.6
357 Tumor -0.6
635 Tumor -0.6
857 Tumor -0.6
536 Normal -0.6
185 Tumor -0.6
721 Tumor -0.7
445 Tumor -0.7
571 Tumor -0.7
715 Tumor -0.7
161 Tumor -0.7
187 Tumor -0.7
685 Tumor -0.7
113 Tumor -0.7
461 Tumor -0.7
421 Tumor -0.8
257 Tumor -0.8
963 Tumor -0.8
411 Tumor -0.8
823 Tumor -0.8
557 Tumor -0.8
863 Tumor -0.8
191 Tumor -0.8
341 Tumor -0.8
517 Tumor -0.9
533 Tumor -0.9
883 Tumor -0.9
213 Tumor -0.9
563 Tumor -1.0
953 Tumor -1.0
271 Tumor -1.0
727 Tumor -1.0
221 Tumor -1.0
447 Tumor -1.0
814 Normal -1.0
443 Tumor -1.0
227 Tumor -1.0
463 Tumor -1.0
925 Tumor -1.1
297 Tumor -1.1
641 Tumor -1.1
777 Tumor -1.1
467 Tumor -1.1
387 Tumor -1.1
553 Tumor -1.1
473 Tumor -1.1
913 Tumor -1.1
393 Tumor -1.1
125 Tumor -1.1
391 Tumor -1.1
147 Tumor -1.1
1013 Tumor -1.1
917 Tumor -1.1
567 Tumor -1.1
455 Tumor -1.2
943 Tumor -1.2
647 Tumor -1.2
277 Tumor -1.2
1043 Tumor -1.2
355 Tumor -1.2
813 Tumor -1.2
491 Tumor -1.2
483 Tumor -1.3
881 Tumor -1.3
877 Tumor -1.3
363 Tumor -1.3
313 Tumor -1.3
737 Tumor -1.3
525 Tumor -1.3
937 Tumor -1.3
975 Tumor -1.3
617 Tumor -1.3
135 Tumor -1.3
343 Tumor -1.3
663 Tumor -1.3
425 Tumor -1.3
965 Tumor -1.4
1031 Tumor -1.4
413 Tumor -1.4
713 Tumor -1.4
427 Tumor -1.4
923 Tumor -1.4
921 Tumor -1.4
1025 Tumor -1.4
1021 Tumor -1.4
493 Tumor -1.5
471 Tumor -1.5
383 Tumor -1.5
351 Tumor -1.5
395 Tumor -1.5
331 Tumor -1.5
537 Tumor -1.5
983 Tumor -1.5
967 Tumor -1.6
311 Tumor -1.6
671 Tumor -1.6
851 Tumor -1.6
815 Tumor -1.6
865 Tumor -1.6
523 Tumor -1.6
957 Tumor -1.6
527 Tumor -1.6
375 Tumor -1.7
497 Tumor -1.7
367 Tumor -1.7
951 Tumor -1.7
131 Tumor -1.7
573 Tumor -1.8
223 Tumor -1.8
817 Tumor -1.8
385 Tumor -1.8
724 Normal -1.8
743 Tumor -1.9
697 Tumor -1.9
545 Tumor -2.0
661 Tumor -2.0
283 Tumor -2.0
285 Tumor -2.1
211 Tumor -2.2
535 Tumor -2.3
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA023371

Antibody HPA023863
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Cholangiocarcinoma
Carcinoma, Hepatocellular, NOS

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org